Buyers seem to be lining up a little more providing strong...

Buyers seem to be lining up a little more providing strong support at mid-30s. (who'd have thought we'd be hoping for that a few months back) and maybe looking for a trigger to start buying again. Would have thought the trial results would have done the trick, but I guess this market wants guaranteed dollars rather than guaranteed product efficacy - and that means takeover or a deal with big pharma to take apricitabine through Phase 3 and beyond.